{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:58:07Z","timestamp":1791511087201,"version":"4.3.4"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamainternmed.2022.0217","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:36:24Z","timestamp":1647862584000},"page":"482","source":"Crossref","is-referenced-by-count":87,"title":["Outcomes and Safety of History-Based Screening for Medication Abortion"],"prefix":"10.1001","volume":"182","author":[{"given":"Ushma D.","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Raymond","sequence":"additional","affiliation":[{"name":"Gynuity Health Projects, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Koenig","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Coplon","sequence":"additional","affiliation":[{"name":"Maine Family Planning, Augusta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marji","family":"Gold","sequence":"additional","affiliation":[{"name":"RHEDI\/Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bliss","family":"Kaneshiro","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy M.","family":"Boraas","sequence":"additional","affiliation":[{"name":"Planned Parenthood North Central States, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[{"name":"Gynuity Health Projects, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"ioi220007r3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.contraception.2020.01.009","article-title":"A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.","volume":"101","author":"Dzuba","year":"2020","journal-title":"Contraception"},{"key":"ioi220007r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.conx.2020.100049","article-title":"Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.","volume":"2","author":"Upadhyay","year":"2020","journal-title":"Contracept X"},{"issue":"1","key":"ioi220007r6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.contraception.2021.04.010","article-title":"Changes to medication abortion clinical practices in response to the COVID-19 pandemic.","volume":"104","author":"Tschann","year":"2021","journal-title":"Contraception"},{"issue":"1","key":"ioi220007r7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.contraception.2021.03.019","article-title":"Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.","volume":"104","author":"Chong","year":"2021","journal-title":"Contraception"},{"issue":"1","key":"ioi220007r8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai\u2019i during COVID-19: practical experience with multiple care delivery models.","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"issue":"1","key":"ioi220007r9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2021.05.001","article-title":"The disproportionate burdens of the mifepristone REMS.","volume":"104","author":"Thompson","year":"2021","journal-title":"Contraception"},{"issue":"6","key":"ioi220007r12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond.","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"issue":"8","key":"ioi220007r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic.","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"ioi220007r15","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/bjo.v128.9","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"issue":"4","key":"ioi220007r16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project.","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"issue":"4","key":"ioi220007r17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks\u2019 gestation: a prospective observational cohort study during the COVID-19 pandemic.","volume":"47","author":"Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"ioi220007r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.conx.2020.100023","article-title":"Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.","volume":"2","author":"Wiebe","year":"2020","journal-title":"Contracept X"},{"issue":"6","key":"ioi220007r19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the US.","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"key":"ioi220007r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.113747","article-title":"State abortion policies and Medicaid coverage of abortion are associated with pregnancy outcomes among individuals seeking abortion recruited using Google Ads: a national cohort study.","volume":"274","author":"Upadhyay","year":"2021","journal-title":"Soc Sci Med"},{"issue":"5","key":"ioi220007r21","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9717","article-title":"Identifying national availability of abortion care and distance from major US cities: Systematic online search.","volume":"20","author":"Cartwright","year":"2018","journal-title":"J Med internet Res"},{"issue":"11","key":"ioi220007r22","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S2468-2667(17)30181-0","article-title":"Innovative models are needed for equitable abortion access in the USA.","volume":"2","author":"Upadhyay","year":"2017","journal-title":"Lancet Public Health"},{"key":"ioi220007r23","doi-asserted-by":"publisher","first-page":"53S","DOI":"10.1097\/01.AOG.0000533024.46009.00","article-title":"The TelAbortion Project: delivering the abortion pill to your doorstep by telemedicine and mail [5E].","volume":"131","author":"Chong","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"ioi220007r24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"},{"issue":"2","key":"ioi220007r25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"ioi220007r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"9","key":"ioi220007r28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10654-015-0039-0","article-title":"Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.","volume":"30","author":"Korevaar","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"ioi220007r29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"4","key":"ioi220007r30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"issue":"1","key":"ioi220007r31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/AOG.0000000000000603","article-title":"Incidence of emergency department visits and complications after abortion.","volume":"125","author":"Upadhyay","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"ioi220007r32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion.","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"ioi220007r34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.contraception.2019.07.005","article-title":"Telemedicine for medication abortion.","volume":"100","author":"Upadhyay","year":"2019","journal-title":"Contraception"},{"issue":"5","key":"ioi220007r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11852","article-title":"Factors associated with use of an online telemedicine service to access self-managed medical abortion in the US.","volume":"4","author":"Aiken","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"ioi220007r36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1034\/j.1600-0412.2002.810713.x","article-title":"Symptom-free women at increased risk of ectopic pregnancy: should we screen?","volume":"81","author":"Mol","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"ioi220007r37","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/AOG.0000000000002188","article-title":"Distance traveled for an abortion and source of care after abortion.","volume":"130","author":"Upadhyay","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"ioi220007r38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/AOG.0000000000003357","article-title":"Medication abortion provided through telemedicine in four US states.","volume":"134","author":"Kohn","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"1","key":"ioi220007r39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.contraception.2021.04.017","article-title":"US clinicians\u2019 perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.","volume":"104","author":"Srinivasulu","year":"2021","journal-title":"Contraception"},{"issue":"1","key":"ioi220007r40","first-page":"30","article-title":"\u201cI don\u2019t want to go anywhere else\u201d: patient experiences of abortion in family medicine.","volume":"48","author":"Summit","year":"2016","journal-title":"Fam Med"},{"issue":"2","key":"ioi220007r41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.contraception.2009.01.017","article-title":"Urban female patients\u2019 perceptions of the family medicine clinic as a site for abortion care.","volume":"80","author":"Rubin","year":"2009","journal-title":"Contraception"},{"issue":"11","key":"ioi220007r42","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S2468-2667(17)30158-5","article-title":"Disparities and change over time in distance women would need to travel to have an abortion in the USA: a spatial analysis.","volume":"2","author":"Bearak","year":"2017","journal-title":"Lancet Public Health"},{"key":"ioi220007r1","doi-asserted-by":"crossref","DOI":"10.1363\/2019.30760","volume-title":"Abortion Incidence and Service Availability in the United States, 2017","author":"Jones","year":"2019"},{"key":"ioi220007r43","volume-title":"Obstacle Course: The Everyday Struggle to Get an Abortion in America","author":"Cohen","year":"2020"},{"key":"ioi220007r2","unstructured":"Mifeprex (mifepristone) tablets, for oral use. Prescribing information. Danco Laboratories, LLC; 2016. Accessed November 6, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020687s020lbl.pdf"},{"key":"ioi220007r4","unstructured":"Planned Parenthood. The abortion pill. Accessed November 6, 2021. https:\/\/www.plannedparenthood.org\/learn\/abortion\/the-abortion-pill"},{"key":"ioi220007r10","unstructured":"Committee on Practice Bulletins\u2014Gynecology and the Society of Family Planning. Medication abortion up to 70 days of gestation. ACOG Practice Bulletin No. 225. Accessed April 28, 2021. https:\/\/www.acog.org\/en\/clinical\/clinical-guidance\/practice-bulletin\/articles\/2020\/10\/medication-abortion-up-to-70-days-of-gestation"},{"key":"ioi220007r11","unstructured":"National Abortion Federation. Abortion & COVID-19. Accessed February 15, 2022. https:\/\/prochoice.org\/abortion-covid-19\/"},{"key":"ioi220007r13","unstructured":"Rebouch\u00e9? R, Upadhyay? U. Online clinics show abortion access can survive state restrictions and Roe v Wade threat. Accessed August 29, 2021. https:\/\/www.usatoday.com\/story\/opinion\/2021\/04\/12\/medication-abortion-rights-protected-online-clinics-column\/7106777002\/"},{"key":"ioi220007r27","unstructured":"WWAMI Rural Health Research Center. Rural-Urban Commuting Area (RUCA) codes. Accessed February 16, 2022. https:\/\/familymedicine.uw.edu\/rhrc\/ruca\/"},{"key":"ioi220007r33","unstructured":"Belluck? P. FDA will permanently allow abortion pills by mail. New York Times. December 16, 2021. Accessed December 27, 2021. https:\/\/www.nytimes.com\/2021\/12\/16\/health\/abortion-pills-fda.html"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2790319\/jamainternal_upadhyay_2022_oi_220007_1650900283.21497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:03:38Z","timestamp":1651489418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2790319"}},"subtitle":["A Retrospective Multicenter Cohort Study"],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2022.0217","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}